Musk reached out to Synchron’s founder and chief executive, Thomas Oxley, in recent weeks to discuss a potential deal, the sources said. It is not clear if any transaction would involve a tie-up ...

Musk reached out to Synchron's founder and chief executive, Thomas Oxley, in recent weeks to discuss a potential deal, the sources said. It is not clear if any transaction would involve a tie-up ...

(Stents are already commonly used to deliver medication or clear blood clocks for stroke victims.) The approach, so far, has been warmly received by regulators. Synchron recently announced the ...

Back to Healio Interim results from the COMMAND study evaluating the safety and efficacy of the Synchron brain-computer interface device found no serious adverse device-related events at 12 months ...